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ABSTRACT
Objective: The objective of this study was observed to measure the effect of alpha-mangostin in balancing the ratio of interferon-gamma (IFN-γ) and 
interleukin-10 (IL-10), and the severity of the disease in mice which infected with Mycobacterium tuberculosis multidrug-resistant (TB-MDR).
Method: Infected BALB/c mice were consisted of five groups: Treated with anti-TB drugs+α-mangostin, treated with anti-TB drugs, given α-mangostin 
during treatment, and control group. Cytokine levels of culture supernatant of spleen cells were measured by enzyme-linked immunosorbent assay. 
The number of bacterial colonies was derived from a primary cell culture of bronchoalveolar lavage. Statistical analysis was performed with Anova, 
Kruskal-Wallis test and correlation Pearson, and Spearman-rank test.
Result: Median IFN-γ production was higher in mice, which given with α-mangostin during treatment is 1838.2 pg/ml and control is 1585.5 pg/ml 
compared treated with anti-TB drugs+α-mangostin (1312 pg/ml) and anti-TB drugs (1429.3 pg/ml) (p>0.05). The highest result production of median 
IL-10 in the 3th group is (465.91 pg/ml) and the lowest in the control group is 195.29 pg/ml, p>0.05. Median IFN-γ/IL-10 ratio of the 3th group very 
low (3.94), it means the 3th group is experienced with severity of TB. Alpha-mangostin was decreased in severity of disease based on the number of 
TB-MDR bacterial colonies (p≤0.05).
Conclusion: α-mangostin have an effect on the balancing IFN-γ/IL-10 ratio and reduce a severity of TB-MDR with using immunomodulator.
Keywords: Tuberculosis multidrug-resistant, Alpha-mangostin, Interferon-γ/interleukin-10 ratio, Number of tuberculosis multidrug-resistant 
bacterial colonies.
INTRODUCTION
Tuberculosis (TB) is a deadly human disease brought by TB, 
approximately 9.6 million people suffer from TB and 1.5 million died 
from the disease in 2014 [1]. The three countries that a distinguished as 
the largest number of incidence cases in 2014 were India (2.2 million); 
Indonesia (1 million), with prevalence rate: 647/100.000 [2]; China 
(0.93 million). The strategy of prevention and eradication of TB 
constrained due to drug-resistant TB, in particularly TB multidrug-
resistant (TB-MDR). In 2013s, an estimated 210,000 people died from 
TB-MDR, and there were approximately 480.000 new cases of TB-MDR 
worldwide [1].
Individuals are infected with TB, only 5-10% developed with TB active 
as a consequence defect of T-cells and macrophages function or the 
ability of phagocytosis [3]. The activity of T-cells (lymphocytes T) was 
sensitized, and macrophage activation is key to host immunity against 
intracellular infections such as pulmonary TB [4]. Protection against M. 
TB infection is a function of the interaction between host T-cells and 
macrophages and that is coordinated by cytokines [5]. Macrophages 
represent the first line of defense against invading bacterial pathogens 
such as Mycobacterial TB (MTB) [6].
Stimulation of antigen MTB will response T-cells, T-cell CD4+ play a 
major role to against microbial infection by secreting pro-inflammatory 
cytokines such as interferon-gamma (IFN-γ). T-cells in the sensitized 
individuals produce IFN-γ when they exposure the antigens of MTB [7]. 
IFN-γ produced by the activation of CD4+ T-cells, CD8+ T-cells, and NK 
cells (Natural Killer cells). The principal effectors of innate immunity 
against intracellular bacteria are phagocytes and NK cells. NK cells 
were produced IFN-γ as a triggers the activation of macrophages 
and increasing destruction of intracellular bacteria such as MTB [4]. 
Cytokine IFN-γ stimulated and activated macrophages to produce 
a substance that eliminates bacteria, including oxidase enzyme in 
phagocytes, such as reactive oxygen intermediates (ROI), enzyme 
inducible nitric oxide synthase, and enzyme lysozyme [4-8].
Recognition of MTB by phagocytic cells results in cell activation and 
production of cytokines, which in itself induced further activation and 
cytokine production in a complex process up regulation and down 
regulation. Several cytokine plays a key role in proinflammatory 
mechanism and the outcome of mycobacterial infections [3]. IFN-γ 
production in response to MTB was lowered in patients with TB, 
particularly in those with far advanced disease [9]. The T-cell response 
develops especially T-cell CD4+ may contribute to differences in 
susceptibility to the disease or outcome [3]. As well as in uncontrolled 
infection of TB, the activated macrophages by stimulating IFN-γ 
caused tissue damage, therefore required inhibition cytokine such 
as IL-10 [10]. Interleukin-10 (IL-10) inhibits the protective immune 
response to pathogens by blocking the production of pro-inflammatory 
cytokines, such as IFN-γ, by direct action antigen-presenting cells 
(APCs) such as macrophages [11]. Meta-analysis recently published 
reinforces the critical importance of IFN-γ as a genetic marker for TB 
resistant, while IL-10 indeed had some specific effect on TB the disease 
and severity but does not affect the susceptibility [12].
IL-10 produced by Th2 cells and a subset of T-cells including cells Th 17, 
B cells, neutrophils, macrophages, dendritic cells, and T regulatory cells 
(Tregs) [11]. Tregs are a subpopulation of CD4+ T-cells, expressing and 
secreting IL-10 and TGF-β, cytokine IL-10 as a barrier and decreasing 
Th 1 cell response in patients with TB infection. Tregs cells are a major 
source of cytokines IL-10, which serves to suppressed the function of 
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APC and macrophages activation [4,5]. Infections TB were performed 
in mice showed that macrophages with excessive production of 
IL-10 causes of decreased production of ROI and RNI and reduced the 
function macrophages [11].
Severity and pathological damage because of the infection depend 
on the balancing between pro-inflammatory and anti-inflammatory 
cytokines (IFN-γ/IL-10), which is related to the ability to control 
granulomatous or control bacterial burden or the number of bacteria 
in granuloma. Infection of mice with MTB can be increased fatality rate. 
It caused a higher number of bacterial TB or highly bacterial burden 
in mice [13]. Pro- and anti-inflammation cytokines play a key role in 
protection and pathogenesis of mycobacterial infection, and their 
balance and dynamic changes may control or predict clinical outcome. 
Balancing cytokines between Th1 and Th2 subset (IFN-γ/IL-10 ratio) 
may influence disease outcome and significantly correlated with TB 
cure [14]. Balancing between differences types of cytokine, especially 
IFN-γ/IL-10 ratio was associated with more killing of numerous MTB 
in granuloma [14,15].
It is now generally accepted that new drugs to cure TB are urgently 
needed due to the recent increment of TB-MDR. The development of 
new drugs to cure TB is urgently needed based on the structure and 
modification of drugs derived from herbal products [17]. The xanthones, 
α- and γ-mangostin, are major bioactive compounds found in fruit 
hulls of the mangostin [18]. α-mangostin has some pharmacological 
activities such as antioxidant [19], anti-TB [16,19], MTB-MDR [19,20], 
anti-inflammatory activities [21], pro-inflammatory activities [18], and 
increased the permeability of the bacterial cell membrane [22-24]. The 
compound α-mangostin is expected to contribute to the fight against 
and eliminate TB infection and MTB-MDR [16,19]. The purpose of this 
research is to know the effect of α-mangostin in balancing the ratio of 
cytokines pro-inflammation (IFN-γ) and anti-inflammation (IL-10) and 
severity of disease in mice which infected with MTB-MDR.
METHODS
Animals
Male BALB/c mice (6-8 weeks old) were obtained from an animal 
laboratory at the Health of Medicine Study Program, School of Health 
Science Jenderal Achmad Yani Cimahi and Drug-Screening Laboratory 
at faculty of medicine Diponegoro University. Mice were housed in 
environmentally controlled animal facilities and the animal room 
maintained at 25°C with a 12 hrs light or dark cycle; mice were 
acclimated for at least 1 week. All experiments were approved by 
Health Research Ethics Committee Faculty of Medicine, University 
Diponegoro and General Hospital Dr. Kariadi Semarang, Central Java 
with the number of Ethical Clearance 573/EC/FK-RSDK/2015.
Bacteria and infection
Isolate of TB-MDR strains from patients with active TB at the Health 
Laboratory of West Java Province. Four groups of mice (each contains 
from 5 mice) were infected by 0.1 ml of bacterial suspension per mice 
(dose of 105 to 106 viable colony forming unit or CFU) through tail vein 
injection. The group of infected mice was observed for 28 days and the 
dead time for each group was recorded. Compound of α-mangostin 
obtained from Aktin Chemical, Inc. Hi-Tech Zone, Yongfeng Plaza, No 52 
Yongfeng Road Chengdu China.
Experimental design
The design of this study is using a posttest with the only control group 
design. 20 mice were randomized and divided into 4 groups, Group I: 
Fourteen (14) day after infection treated with α-mangostin with 
human-equivalent doses of 6.95 mg/kg body weight and anti-TB drugs 
(once a day given per oral); Group II: Treated with anti-TB drugs given. 
In Group III was given α-mangostin during treatment (early stage given 
α-mangostin in 1-7 days, then infected with TB-MDR at 7-21 day and 
given anti-TB drugs at 21-28 day observation). The control group was 
infected TB-MDR without treatment (positive control).
Cytokine measurement
After 28 days of treatment, mice were sacrificed used by cervical 
dislocation. Spleens from twenty mice (each contains 5 mice) were 
removed rapidly after sacrifice and a sterile autopsy were performed. 
The organs were transferred into 2 mm diameter glass beads each 
containing 1 ml FBS (fetal bovine serum). Spleen lymphocytes were 
extracted, and 3×107/ml lymphocytes were cultured in 24-well plates 
in the RPMI-1640 cell culture medium containing 10% FBS and 
100 U/ml penicillin, 100 μg/ml streptomycin and stimulated with 
HPA. Supernatants were collected after 48 and 72 hours and then 
plates incubated in 5% CO2 at 37°C. IFN-γ and IL-10 production were 
measured by enzyme-linked immunosorbent assay using Mouse IFN 
gamma Quantikine Cat. No. MIF00 and Mouse IL-10 Quantikine Cat. No. 
M10000B, following the manufacturer protocol. Standard curves for 
each cytokine were generated using reference cytokine concentration 
supplied by the manufacturer.
Bronchoalveolar lavage (BAL) and histology of the lung
BAL has been widely used for clinical research because BAL fluid 
contains both biochemical and cytological indicators of cellular 
responses to infection include TB infection [25]. Bronchoalveolar 
lavage used to know of a number of colonies multidrug-resistant MTB. 
The abdominal cavity was opened, exsanguination was performed via 
the aorta abdominalis, and the chest cavity was dissected to expose 
the lung and the trachea. One (1) ml syringe connected 27 gauges and 
then gently inserted into the trachea and 0.9 ml chilled saline was 
administered and aspirated slowly through the needle hub. The liquid 
of bronchoalveolar lavage (BAL) accommodated with micro tube 1 ml. 
Bronchoalveolar lavage stored at 2-8°C before culture and incubation. 
Bronchoalveolar lavage cultured and incubation on Lewenstein Jensen 
medium at 35-37°C and observed for 8 weeks. The present bacterial 
TB in mice with infected MTB-MDR is confirmed from the histology of 
the lung tissue and staining with Ziehl-Neelsen method to find acid-fast 
bacilli.
Statistical analysis
Results are reported in the mean±standard deviation (SD), median, 
minimum, and maximum value. To compare the differences mean of 
cytokines (IFN-γ and IL-10) between four groups were calculated 
using Anova (statistical parametric), while differences mean number of 
bacterial colonies used Kruskal-Wallis test (statistically nonparametric). 
The correlation cytokines IFN-γ and IL-10 with IFN-γ/IL-10 ratio were 
assessed using correlation pearson (statistical parametric), and the 
correlation between IFN-γ/IL-10 and the number of bacterial colonies 
used Spearman-rank test (statistical nonparametric). Correlation 
coefficients were calculated and identified as very weak (0-0.19), weak 
(0.20-0.39), moderate (0.40-0.59), strong (0.60-0.79), or very strong 
(0.80-1.0). All statistical analyses were one sided, and p≤0.05 was 
considered as statistically significant.
RESULTS
The median of pro-inflammatory cytokine (IFN-γ) was strongly 
increased to response TB infection in the 3rd group that was given 
α-mangostin during treatment (1838.2 pg/ml) and lowest in the 
group treated with anti-TB drugs and α-mangostin (1312 pg/ml). The 
results of data analysis showed that administration of alpha-mangostin 
in the Groups 1-3 and control groups did not significantly increased 
IFN-γ production (p>0.05) (Table 1). Median IL-10 production was 
strongly depressed to response TB infection in the control group 
(195.29 pg/ml), and the highest in the group was given α-mangostin 
during treatment (465.91 pg/ml). Maximal value IL-10 in the group was 
given α-mangostin during treatment (1090.7 pg/ml). The data analysis 
has shown that the production capacity of IL-10 in the treatment 
Group 1-3 and control groups did not statistically significant (p>0.05) 
(Table 1).
The median IFN-γ/IL-10 ratio is the lowest in the group treated with 
anti-TB drugs and α-mangostin and it was 3.94, this due to higher 
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production of cytokine pro-inflammation (IFN-γ) followed by higher 
production of cytokine anti-inflammation (IL-10). The lowest value 
IFN-γ/IL-10 ratio in the group was given α-mangostin during the 
treatment (0.80), it means in the 3rd group showed the severity of 
TB infection, it was indicated with the highest number of bacterial 
colonies TB-MDR. Alpha-mangostin did not significant to compare 
mean IFN-γ/IL-10 ratio in treatment Group 1-3 (p>0.05). The result 
completely is shown in Table 1.
The number of colonies MTB-MDR from culture bronchoalveolar 
lavage, the higher count of bacterial colonies in the 3rd group, it was 
given α-mangostin during treatment. The number of colonies in the 
3rd group: 11 colonies, large colonies, color colonies of bacteria: Buff 
and dry, (shown in Fig. 1a). Result histology of the lung tissue in mice 
infected with TB-MDR found acid-fast bacilli (Fig. 1b). In the control 
group, maximal count of bacteria is 5 colonies MTB-MDR. While group 
treated with anti-TB drugs and α-mangostin and the group treated with 
anti-TB drugs (1st and 2nd group) bacterial colonies were zero (0), it’s 
mean administration α-mangostin can be used to eliminated and killing 
TB-MDR. In this research, administration alpha-mangostin after an 
incubation period of TB infection (14th day after infection) significant to 
decreased number of bacterial colonies MTB-MDR (p≤0.05) (Table 1).
The results reveal a positive correlation between the production of 
cytokine IFN-γ was correlated with IFN-γ/IL-10 ratio (r=0.39; p≤0.05), 
it was positive correlation that means the higher production of cytokine 
IFN-γ increased of IFN-γ/IL-10 ratio (Fig. 2). The coefficient correlation 
between cytokine IFN-γ and IFN-γ/IL-10 ratio categorized weak. IFN-γ 
production capacity contributed 12.9% to increase the ratio of IFN-γ/
IL-10 (R2=0.129).
The correlation between production capacity of IL-10 and IFN-γ/IL-10 ratio 
was negative correlation (r= -0.57; p≤0.01), it means that the higher of 
production IL-10 can caused to decreased of IFN-γ/IL-10 ratio (Fig. 2). 
The coefficient correlation between of IL-10 and IFN-γ/IL-10 ratio was 
moderate correlation. IFN-γ production capacity contributed to 32.5% to 
increase the ratio of IFN-γ/IL-10 (R2=0.325).
The correlation between IFN-γ/IL-10 ratio and the number of bacterial 
colonies TB-MDR was a negative correlation (r=−0.398; p≤0.05), it 
means that the lower of IFN-γ/IL-10 ratio can cause to increase of 
the number of bacterial colonies TB-MDR (Fig. 3). The coefficient 
correlation between IFN-γ/IL-10 ratio was categorized weak. The ratio 
of IFN-γ/IL-10 contributed to 7.9% to increase the number of bacterial 
colonies TB-MDR (R2=0.079).
DISCUSSION
After inhalation with cMTB in the lungs, the first cells to be exposed 
to the microbial include alveolar macrophages and dendritic cells 
(DCS) of the lung, both of which readily phagocytosis MTB and become 
activated, producing the cytokines TNF-γ, IFN-γ and IL-12 to promote 
host antimicrobial mechanisms [11], and initiating the activation of T 
helper (Th) cells [26]. In mycobacterial infection, Th1 type cytokines 
especially pro-inflammatory cytokines such as the capacity production 
of IFN-γ plays an important role in protective immunity and the 
establishment of innate immunity against MTB [27]. While Th2 type 
cytokines or anti-inflammatory cytokine especially IL-10 inhibited 
production of IFN-γ [3].
The clinical manifestations of infection with MTB and severity of disease 
in TB infection indicated they changed in balancing of cytokines that 
play a part in the MTB infection. The balancing of pro-inflammatory 
cytokines and anti-inflammatory is a very significant sign related to the 
progression of TB infection [5,28]. IFN-γ may be one of the keys cytokine 
in the activation of macrophages for elimination and killing MTB. IL-10 
of particular importance in reducing collateral tissue damage due to 
Table 1: Mean±SD, median, minimal and maximal value of cytokines IFN‑γ (pg/ml), IL‑10 (pg/ml), IFN‑γ/IL‑10 ratio and number of 
bacterial colonies TB‑MDR
Mice groups (n=5) IFN‑γ (pg/ml) IL‑10 (pg/ml) IFN‑γ/IL‑10 ratio Number of bacterial 
colonies TB‑MDR
I
Mean 1365.94±878.42* 230.37±67.29* 7.23±6.61* 0
Median 1312.0 255.58 6.62 0
Minimal 383.05 128.15 1.35 0
Maximal 2312.6 285.73 18.05 0
II
Mean 1649.62±613.22* 260.93±146.94* 8.73±6.10* 0
Median 1429.3 207.62 5.77 0
Minimal 1063.1 81.56 2.42 0
Maximal 2392.9 439.88 17.52 0
III
Mean 1591.29±802.16* 450.75±409.75* 10.65±13.33* 2.8±4.6*
Median 1838.2 465.91 3.94 0
Minimal 404.89 36.35 0.80 1
Maximal 2417.2 1090.7 32.78 11
IV
Mean 1488.56±741.88* 176.66±51.35* 10.13±8.29* 1.0±2.236**
Median 1585.5 195.29 8.11 1
Minimal 355.11 90.47 1.69 0
Maximal 2167.6 217.22 23.96 5
*Data given in mean±SD (n=20), **Statistically significant compared to the group I with p≤0.05 (LSD post hoc test), SD: Standard deviation, TB-MDR: Tuberculosis 
multidrug-resistant,  IFN: Interferon, IL: Interleukin
Fig. 1: The number of bacterial colonies of tuberculosis 
multidrug‑resistant, (a) 3rd group: 11 bacterial colonies 
tuberculosis multidrug‑resistant, large colonies, color: Buff and 
dry, (b) Acid fast bacilli from the histology of lung
a b
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the activating IFN-γ, particularly in the lung by dampening macrophage 
activation and by indirectly antagonizing IFN-γ function [5].
Experiments in mice revealed that IFN-γ is an important cytokine for 
macrophage activation and mycobacteria death in the intracellular 
environment [27]. Production IFN-γ in response to M. TB were lowered 
in mice infected with TB, particularly in those with far advanced 
disease [10]. The depression of IFN-γ production contributing to 
defective host control of MTB infection in active TB [14]. Confirming 
prior studies showing that IFN-γ production varies inversely with 
the severity of disease due to MTB [10]. IFN-γ production a higher 
proportion of latent infection TB compares with TB active and 
uninfected healthy individual [29]. A high amount of IFN-γ production 
is then assumed to be correlated with TB infection [7]. In this research 
shown that IFN-γ production is more higher in the 3rd group, that was 
given α-mangostin during treatment and control group compare with 
the 1st group treated with anti-TB drugs and α-mangostin, its mean in 
the 1st group health status and immunity in 1st group increased and lead 
to the cure of multidrug-resistant MTB infection.
Anti-inflammatory cytokine (IL-10) managed a delicate balance 
between suppressing and activating host responses to microbial 
infection [11]. Increased IL-10 production in TB infection may hinder 
and inhibitor T-cell responses [5]. The highest result of IL-10 production 
may over control otherwise protective T-cell responses, causes high 
microbial load, which can lead to chronic infection, while small amount 
or depression of IL-10 production can be caused fatal host-mediated 
pathology. In this research, the 3th group becomes over control of IL-
10 production and IL-10 depressed production in the control group 
that indicated progression and severity of TB infection in mice. This 
research in line with research Anshari et al. (2009) declared that IL-10 
have a specific effect on TB infection, role of determining for severity of 
disease, but not susceptibility.
In this research reported that the ratio of cytokines (IFN-γ/IL-10) 
shows significant correlation with clinical severity in mice with infected 
TB-MDR based on number of bacterial colonies TB-MDR, lowest 
IFN-γ/IL-10 ratio relating to severe disease, particularly in the 3rd group. 
In the 3rd group, MTB grow in culture with the number of bacterial 
colonies were 11 colonies, large colonies, color colonies are buff and dry. 
While the control group was growing 5 colonies of TB-MDR bacteria. 
Administration of α-mangostin had an effect on the number of bacterial 
colonies in mice infected with MTB-MDR compared between the control 
group and the group was given α-mangostin during treatment.
IFN-γ/IL-10 ratio was considered to be particularly regulated 
biomarker signatures that correlated strongly with TB cure [14]. The 
IFN-γ/IL-4 ratio was increased in most patients during therapy but 
was decreased in contacts that become ill, suggesting that this state is a 
direct consequence of the disease [30]. The IFN-γ/IL-10 ratio increased 
in mice with α-mangostin therapy and it means that the administration 
α-mangostin associated with a cure of pulmonary TB. And while in the 
3rd group (α-mangostin during treatment), IFN-γ/IL-10 ratio lowest 
and depressed, it means that the treatment alpha-mangostin during the 
experiment (before infection, bacterial infection phase, the incubation 
period and after infection) are related to the severity of TB infection.
Natural products are a proven for the development of novel scaffolds 
of drugs such as α-mangostin, the active compound from Garcinia 
mangostana, they are received considerable as potential antimicrobial 
agents and decreased resistance of antibiotics [20,31]. Due to 
emergence of resistance to antibiotics especially MTB, the investigation 
and development of the new anti-TB drugs became a major focus of 
reseachers [31]. The compound of α-mangostin served to increased 
the adaptive immune response to TB infection, of which can increased 
the number of CD4+ T-cells or CD8+ T-cells [19], by increasing the 
number of T-cells, so as to achieve an amount sufficient to stop the 
growth of TB bacteria [32]. Therefore the compound of α-mangostin 
significantly increased the immune response and health status [19]. 
Alpha-mangostin can be used as adjuvant treatment of multidrug-
resistant MTB infection. That can be used to reduce the progression and 
severity of TB infection. Period administration of α-mangostin must be 
considered and should be given in the period between 2-3 weeks post-
infection, particularly on 14th day after infected, which is in the period 
of T-cells become activated and differentiated to be an effector cells and 
begin to proliferated in tubercles and then activating the macrophages 
to eliminated and killing MTB [32].
CONCLUSION
Alpha-mangostin have an effect on the balancing cytokines of pro-
inflammatory and anti-inflammatory (IFN-γ/IL-10 ratio), it can be 
eliminated and killing mycobacterial, therefore can decrease the severity 
of TB infection. Alpha-mangostin can be used as immunomodulatory or 
adjuvant treatment against MTB-MDR.
ACKNOWLEDGMENTS
This research was funded in part by desentralisasi 2015 grants from 
the Indonesian Ministry of Research and Technology. Scholarships from 
Fig. 2: Corelation of cytokines interferon‑gamma/interleukin‑10 
with interferon‑gamma/interleukin‑10 ratio
Fig. 3: Corelation of interferon‑gamma/interleukin‑10 ratio 
and number of bacterial colonies of Mycobacterium tuberculosis 
multidrug‑resistant
Variable Correlation (r) Coefficient of 
determination 
(R2)
IFN-γ with IFN-γ/IL-10 ratio 0.39 0.129
IL-10 with IFN-γ/IL-10 ratio −0.57*** 0.325
IFN-γ/IL-10 ratio with number 
of bacterial colonies TB-MDR
−0.398** 0.079
**statistically significant (p≤0.05), ***statistically significant (p≤0.01), 
TB-MDR: Tuberculosis multidrug-resistant, INF: Interferon, IL: Interleukin
Table 2: Correlation cytokine IFN‑γ (pg/ml) and IL‑10 
(pg/ml) with IFN‑γ/IL‑10 ratio and number of bacterial 
colonies TB‑MDR
Asian J Pharm Clin Res, Vol 9, Suppl. 3, 2016, 273-277
 Nugrahaeni et al. 
277
BPP-DN, Indonesia Ministry of Research and Technology. We thank to 
Dr. Muchlis AUS., SpPD-KPTI, Prof. Dr. dr. Hertanto WS., MS. Sp.GK, Dr. dr 
Sri Andarini I., M.Kes, Professor Dr. dr. Hendro W., M.Sc. Tropmed, DMM, 
Sp.MK and Rasipin dr, M.Kes to their contribution of this research.
REFERENCES
1. WHO. Global Tuberculosis Report 2013. Geneva: World Health 
Organization; 2013.
2. WHO. Tuberculosis Profile. Geneva: World Health Organization; 2014.
3. van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to 
Mycobacterium tuberculosis. Clin Microbiol Rev 2002;15(2):294-309.
4. Baratawidjaja K, Rengganis I. Imunologi Dasar. 12th ed. Jakarta: Balai 
Penerbit Fakultas Kedokteran Universitas Indonesia; 2014.
5. Masood KI, Rottenberg ME, Salahuddin N, Irfan M, Rao N, Carow B, 
et al. Expression of M. Tuberculosis-induced suppressor of cytokine 
signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates 
with differing clinical severity of tuberculosis. BMC Infect Dis 
2013;13:13.
6. Weiss G, Schaible UE. Macrophage defense mechanisms against 
intracellular bacteria. Immunol Rev 2015;264(1):182-203.
7. Preeti S, Pradeep K, Rachna S, Kumar AV. Futuristic scope of 
biomarkers in tuberculosis. Asian J Pharm Clin Res 2015;8(4):248-50.
8. Murphy K. Janeway’s Immuno Biology. 8th ed. New York, USA: 
Garland Sciences, Tailor & Francis Group, LLC and Informa Bussines; 
2011.
9. Kuo HP, Wang CH, Huang KS, Lin HC, Yu CT, Liu CY, et al. Nitric 
oxide modulates interleukin-1beta and tumor necrosis factor-alpha 
synthesis by alveolar macrophages in pulmonary tuberculosis. Am J 
Respir Crit Care Med 2000;161(1):199-2.
10. Shams H, Wizel B, Weis SE, Samten B. Contribution of CD8(+) T cells 
to gamma interferon production in human tuberculosis. Infect Immun 
2001;69(5):3497-501.
11. Redford P, Murray P, Garra A. The role of IL-10 in immune regulation 
during M. tuberculosis infection. Mucosal Immunol 2011;4(3):261-70.
12. Ansari A, Talat N, Jamil B, Hasan Z, Razzaki T, Dawood G, et al. 
Cytokine gene polymorphisms across tuberculosis clinical spectrum in 
Pakistani patients. PLoS One 2009;4(3):e4778.
13. Ufimtseva E. Mycobacterium-host cell relationships in granulomatous 
lesions in a mouse model of latent tuberculous infection. Biomed Res 
Int 2015;2015:948131.
14. Sahiratmadja E, Alisjahbana B, De Boer T, Adnan I, Maya A, 
Danusantoso H, et al. Dynamic changes in pro-and anti-inflammatory 
cytokine profiles and gamma interferon receptor signaling integrity 
correlate with tuberculosis disease activity and response to curative 
treatment. Infect Immun 2007;75(2):820-9.
15. Gideon HP, Phuah J, Myers AJ, Bryson BD, Rodgers MA, Coleman MT, 
et al. Variability in tuberculosis granuloma T cell responses exists, but 
a balance of pro- and anti-inflammatory cytokines is associated with 
sterilization. PLoS One 2015;11(1):e1004603.
16. Silva MM, Breiman A, Allain S, Deknuydt F, Altare F. The tuberculous 
granuloma: An unsuccessful host defense mechanism providing a 
safety shelter for the bacteria? Clin Dev Immunol 2012;2012:139127.
17. Suksamrarn S, Suwannapoch N, Phakhodee W, Thanuhiranlert J, 
Ratananukul P, Chimnoi N, et al. Antimycobacterial activity of 
prenylated xanthones from the fruits of Garcinia mangostana. Chem 
Pharm Bull 2003;51(7):857-9.
18. Gutierrez-Orozco F, Failla ML. Biological activities and bioavailability 
of mangostin xanthones: A critical review of the current evidence. 
Nutrients 2013;5(8):3163-83.
19. Tang YP, Li PG, Kondo M, Ji HP, Kou Y, Ou B. Effect of a mangostin 
dietary supplement on human immune function: A randomized, double-
blind, placebo-controlled trial. J Med Food 2009;12(4):755-63.
20. Sudta P, Jiarawapi P, Suksamrarn A, Hongmanee P, Suksamrarn S. Potent 
activity against multidrug-resistant Mycobacterium tuberculosis of 
α-mangostin analogs. Chem Pharm Bull (Tokyo) 2013;61(2):194-203.
21. Koh J, Lin S, Aung TT, Lim F, Zou H, Bai Y, et al. Amino acid 
modified xanthone derivatives: Novel, highly promising membrane-
active antimicrobials for multidrug-resistant gram-positive bacterial 
infections. J Med Chem 2015;58(2):739-52.
22. Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of 
mangosteens from Garcinia mangostana. Food Chem Toxicol 
2008;46(2):688-93.
23. Koh J, Qiu S, Zou H, Lakshminarayanan R, Li J, Zhou X, et al. Rapid 
bactericidal action of alpha-mangostin against MRSA as an outcome of 
membrane targeting. Biochim Biophys Acta 2013;1828(2):834-44.
24. Sato A, Fujiwara H, Oku H, Ishiguro K, Ohizumi Y. Alpha-Mangostin 
induces Ca2+-ATPase-dependent apoptosis via mitochondrial pathway 
in PC12 Cells. J Pharmacol Sci 2004;95(1):33-40.
25. Song J, Yang H, Lee J, Kwon S, Jung KJ, Heo JD, et al. Standardization 
of bronchoalveolar lavage method based on suction frequency number 
and lavage fraction number using rats. Toxicol Res 2010;26(3):203-8.
26. Wolf AJ, Linas B, Trevejo-Nuñez GJ, Kincaid E, Tamura T, 
Takatsu K, et al. Mycobacterium tuberculosis infects dendritic cells 
with high frequency and impairs their function in vivo. J Immunol 
2007;179(4):2509-19.
27. Cavalcanti YV, Brelaz MC, Neves JK, Ferraz JC, Pereira VR. Role of 
TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary 
tuberculosis. Pulm Med 2012;2012:745483.
28. Marakalala M, Raju R, Sharma K, Zhang YJ, Eugenin EA, Prideaux B, 
et al. Inflammatory signaling in human tuberculosis granulomas is 
spatially organized. Nat Med 2016;22(5):531-8.
29. Bai XJ, Liang Y, Yang YR, Li N, Zhang XY, An HR, et al. Immune 
responses to latent tuberculosis antigen Rv2659c in Chinese 
populations. J Microbiol Immunol Infect 2015;48(4):381-9.
30. Abebe M, Kim L, Rook G, Aseffa A, Wassie L, Zewdie M, et al. 
Modulation of cell death by M. tuberculosis as a strategy for pathogen 
survival. Clin Dev Immunol 2011;2011:678570.
31. Sreerag RS, Dileep C, Sasidharan NK. Antimycobacterail 
activity of crude extracts produces by Bacillus sp. associated with 
entomophatogenic nematode. Asian J Pharm Clin Res 2014;6(9):6-8.
32. Shi R, Sugawara I. Pathophysiology of tuberculosis. Tuberculosis: 
Current Issues in Diagnosis and Management. Croatia: InTech; 2013. 
p. 127-38.
